| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Adriana Albu | |
| Mihai Porojan | |||
| Ioana Para | |||
| P2860 | cites work | Relationship between Serum Uric Acid and Vascular Function and Structure Markers and Gender Difference in a Real-World Population of China-From Beijing Vascular Disease Patients Evaluation Study (BEST) Study | Q47640735 |
| Xanthine oxidase inhibition protects against Western diet-induced aortic stiffness and impaired vasorelaxation in female mice. | Q47754216 | ||
| Multimarker Analysis for New Biomarkers in Relation to Central Arterial Stiffness and Hemodynamics in a Chinese Community-Dwelling Population | Q48225509 | ||
| Purification and immunohistochemical tissue localization of human xanthine oxidase | Q48233785 | ||
| Serum uric acid is associated with arterial stiffness in men with newly diagnosed type 2 diabetes mellitus | Q48875986 | ||
| Relationships between mild hyperuricaemia and aortic stiffness in untreated hypertensive patients. | Q48876587 | ||
| Arterial stiffness and central arterial wave reflection are associated with serum uric acid, total bilirubin, and neutrophil-to-lymphocyte ratio in patients with coronary artery disease | Q49166468 | ||
| Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials | Q49584618 | ||
| Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus | Q50035022 | ||
| Age-adjusted level of circulating elastin as a cardiovascular risk factor in medical check-up individuals. | Q50917619 | ||
| Long-term application of the aldosterone antagonist spironolactone prevents stiff endothelial cell syndrome. | Q50943091 | ||
| Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients (NU-FLASH Trial). | Q50991649 | ||
| Uric acid metabolism in pre-hypertension and the metabolic syndrome. | Q51032258 | ||
| Serum uric acid and arterial stiffness in hypertensive chronic kidney disease patients: sex-specific variations. | Q51136372 | ||
| The impact of serum uric acid level on arterial stiffness and carotid atherosclerosis: the Korean Multi-Rural Communities Cohort study. | Q51193329 | ||
| Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness | Q22306395 | ||
| Hyperuricemia, Cardiovascular Disease, and Hypertension | Q26747880 | ||
| Uric acid, hyperuricemia and vascular diseases | Q26850727 | ||
| Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease | Q27024623 | ||
| Towards the physiological function of uric acid | Q27863441 | ||
| Transforming growth factor beta in tissue fibrosis | Q28239292 | ||
| Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis | Q28354735 | ||
| Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. | Q30708800 | ||
| Serum Uric Acid and Pulse Wave Velocity Among Healthy Adults: Baseline Data From the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). | Q30885481 | ||
| Effect of allopurinol on blood pressure: a systematic review and meta-analysis | Q31118679 | ||
| The association between serum urate levels and arterial stiffness/endothelial function in stroke survivors | Q33317865 | ||
| Role of inflammation in the pathogenesis of arterial stiffness | Q33352994 | ||
| Hyperuricemia and risk of increased arterial stiffness in healthy women based on health screening in Korean population. | Q33860337 | ||
| Expert consensus document on arterial stiffness: methodological issues and clinical applications | Q33999785 | ||
| Relationship Between Serum Uric Acid Levels, Metabolic Syndrome, and Arterial Stiffness in Korean | Q34021181 | ||
| Systolic hypertension, arterial stiffness, and vascular damage: role of the renin-angiotensin system | Q34087528 | ||
| Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional study | Q34338766 | ||
| Uric acid and oxidative stress | Q34479299 | ||
| Synergistic effects of serum uric acid and cardiometabolic risk factors on early stage atherosclerosis: the cardiometabolic risk in Chinese study | Q34531668 | ||
| Uric acid and the development of hypertension: the normative aging study. | Q34576156 | ||
| High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid | Q34585155 | ||
| High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies | Q34599618 | ||
| Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis | Q35036205 | ||
| Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study | Q35121532 | ||
| Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. | Q35166411 | ||
| Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study | Q35579735 | ||
| Hyperuricemia in childhood primary hypertension. | Q35642551 | ||
| Allopurinol and mortality in hyperuricaemic patients | Q35784983 | ||
| Asymptomatic hyperuricemia following renal transplantation | Q35819404 | ||
| Associations of serum uric acid levels with arterial wave reflections and central systolic blood pressure | Q35913379 | ||
| Association of Uric Acid With Vascular Stiffness in the Framingham Heart Study | Q35975531 | ||
| Effects of Allopurinol on Arterial Stiffness: A Meta-Analysis of Randomized Controlled Trials | Q35998065 | ||
| EGCG Attenuates Uric Acid-Induced Inflammatory and Oxidative Stress Responses by Medicating the NOTCH Pathway | Q36204537 | ||
| Serum uric Acid level and diverse impacts on regional arterial stiffness and wave reflection | Q36311008 | ||
| The Association of Endothelin-1 with Markers of Arterial Stiffness in Black South African Women: The SABPA Study. | Q36448456 | ||
| Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness. | Q36832994 | ||
| Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. | Q36956768 | ||
| Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells | Q36977685 | ||
| Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease | Q37073587 | ||
| Uric acid secretion from adipose tissue and its increase in obesity | Q37189456 | ||
| Uric acid and long-term outcomes in CKD | Q37214752 | ||
| Association between serum uric acid and development of type 2 diabetes. | Q37319097 | ||
| Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes | Q37325818 | ||
| Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome | Q37447055 | ||
| Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review | Q37626339 | ||
| Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice | Q37676966 | ||
| Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis | Q37719080 | ||
| Peripheral arterial stiffness is associated with higher baseline plasma uric acid: A prospective cohort study | Q37728790 | ||
| Significance of high-normal serum uric acid level as a risk factor for arterial stiffness in healthy Korean men. | Q51357723 | ||
| Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. | Q51497733 | ||
| Serum Uric Acid Elevation Is Associated To Arterial Stiffness In Hypertensive Patients With Metabolic Disturbances. | Q52381528 | ||
| Gender-specific association of serum uric acid levels and cardio-ankle vascular index in Chinese adults. | Q52593396 | ||
| Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout. | Q52661324 | ||
| Risks associated with SGLT2 Inhibitors: An Overview. | Q52683656 | ||
| Effects of Uric Acid on the NO Production of HUVECs and its Restoration by Urate Lowering Agents. | Q52883483 | ||
| Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. | Q52930040 | ||
| Depletion of Uric Acid Due to SLC22A12 (URAT1) Loss-of-Function Mutation Causes Endothelial Dysfunction in Hypouricemia. | Q52961963 | ||
| Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis. | Q53061295 | ||
| Relationships between serum uric acid, adiponectin and arterial stiffness in postmenopausal women. | Q53354698 | ||
| Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients with chronic kidney disease (NU-FLASH trial for CKD). | Q53620296 | ||
| Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. | Q53866895 | ||
| Effect of Xanthine Oxidase Inhibition on Arterial Stiffness in Patients With Chronic Heart Failure. | Q55176404 | ||
| Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged Men | Q57303589 | ||
| Association between serum uric acid and arterial stiffness in a low-risk, middle-aged, large Korean population: A cross-sectional study | Q58759139 | ||
| Febuxostat and Cardiovascular Events: A Systematic Review and Meta-Analysis | Q64248747 | ||
| Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury. | Q64993755 | ||
| Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression | Q70144052 | ||
| The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice | Q72996062 | ||
| Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study | Q73295545 | ||
| Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers | Q79301318 | ||
| Nitrosation of uric acid induced by nitric oxide under aerobic conditions | Q79431154 | ||
| Uric acid and cardiovascular risk | Q79689991 | ||
| Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions | Q80800957 | ||
| Association of serum uric acid with aortic stiffness and pressure in a Chinese workplace setting | Q82522316 | ||
| Uric acid and hypertension | Q83281851 | ||
| An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Ja | Q84305957 | ||
| The diverse associations of uric acid with low-grade inflammation, adiponectin and arterial stiffness in never-treated hypertensives | Q85231508 | ||
| High uric acid level associated with increased arterial stiffness in apparently healthy women | Q87635380 | ||
| Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study | Q88689466 | ||
| Cross-sectional and longitudinal associations between serum uric acid and endothelial function in subjects with treated hypertension | Q89080329 | ||
| Association of serum uric acid with subsequent arterial stiffness and renal function in normotensive subjects | Q89286407 | ||
| NF-κB signaling in inflammation | Q89348733 | ||
| Involvement of Arterial Stiffness and Inflammation in Hyperuricemia-Related Development of Hypertension | Q89480999 | ||
| Uric Acid and Hypertension Because of Arterial Stiffness | Q89481017 | ||
| Uric acid induced the phenotype transition of vascular endothelial cells via induction of oxidative stress and glycocalyx shedding | Q90281461 | ||
| Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus | Q90726031 | ||
| Association of Serum Uric Acid with Arterial Stiffness in Peritoneal Dialysis Patients | Q91581341 | ||
| Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis | Q37958283 | ||
| Arterial stiffness and pulse pressure in CKD and ESRD. | Q38005590 | ||
| PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics | Q38219092 | ||
| Relationship between uric acid and vascular structure and function in hypertensive patients and sex-related differences. | Q38455444 | ||
| Regulation of uric acid metabolism and excretion | Q38575684 | ||
| Uric acid promotes vascular stiffness, maladaptive inflammatory responses and proteinuria in western diet fed mice | Q38648316 | ||
| Serum Uric Acid and Arterial Function After Renal Transplantation. | Q38680004 | ||
| Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study | Q38732241 | ||
| Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis. | Q38853112 | ||
| IL-1β production is dependent on the activation of purinergic receptors and NLRP3 pathway in human macrophages | Q38859553 | ||
| Impact of allopurinol on risk of myocardial infarction | Q39033643 | ||
| Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. | Q39718507 | ||
| High levels of serum uric acid are associated with silent brain infarction | Q39851651 | ||
| Association of serum uric acid level with aortic stiffness and arterial wave reflections in newly diagnosed, never-treated hypertension | Q39868931 | ||
| Allopurinol and Cardiovascular Outcomes in Adults With Hypertension. | Q40006291 | ||
| Physiological functions and pathogenic potential of uric acid: A review. | Q40117885 | ||
| Longitudinal Association Between Serum Uric Acid and Arterial Stiffness: Results From the Baltimore Longitudinal Study of Aging | Q40428192 | ||
| The controversial role of serum uric acid in essential hypertension: relationships with indices of target organ damage. | Q40454847 | ||
| High serum uric acid is associated with increased cardio-ankle vascular index (CAVI) in healthy Japanese subjects: a cross-sectional study | Q41532382 | ||
| Association between serum uric acid, aortic, carotid and femoral stiffness among adults aged 40-75 years without and with type 2 diabetes mellitus: The Maastricht Study | Q41619965 | ||
| Cloning and expression of a cDNA encoding an endothelin receptor | Q41710266 | ||
| Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production | Q42127578 | ||
| Hyperuricemia induces endothelial dysfunction | Q42477084 | ||
| Uric acid is an independent predictor of arterial stiffness in hypertensive patients | Q43270430 | ||
| Gender differences in the relationships of serum uric acid with fasting serum insulin and plasma glucose in patients without diabetes | Q43571095 | ||
| Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension | Q43576505 | ||
| Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers | Q43696183 | ||
| Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism | Q43801315 | ||
| A role for uric acid in the progression of renal disease | Q44223958 | ||
| Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis | Q44290620 | ||
| Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid. | Q44300014 | ||
| Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. | Q44438488 | ||
| Uric acid reduces exercise-induced oxidative stress in healthy adults | Q44474566 | ||
| Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers | Q44543066 | ||
| Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation | Q44571703 | ||
| The impact of serum uric acid on cardiovascular outcomes in the LIFE study | Q44761562 | ||
| Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence | Q45166650 | ||
| As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout | Q45823744 | ||
| Hyperuricemia, oxidative stress, and carotid artery tone in experimental renal insufficiency. | Q45971989 | ||
| Serum uric acid concentration and asymptomatic hyperuricemia with subclinical organ damage in general population. | Q46459227 | ||
| Relationship between uric acid and arterial stiffness in the elderly with metabolic syndrome components | Q46459941 | ||
| Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study | Q46736184 | ||
| Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells | Q46776017 | ||
| Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system | Q46809905 | ||
| Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study | Q46839896 | ||
| Lowering serum urate does not improve endothelial function in patients with type 2 diabetes | Q46956141 | ||
| Uric Acid Level Has a J-Shaped Association with Arterial Stiffness in Korean Postmenopausal Women. | Q47112179 | ||
| Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study. | Q47370909 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 39-54 | |
| P577 | publication date | 2020-01-28 | |
| P1433 | published in | Therapeutics and Clinical Risk Management | Q15766913 |
| P1476 | title | Uric Acid and Arterial Stiffness | |
| P478 | volume | 16 |
Search more.